Fierce Biotech December 6, 2023
Medtronic has secured a European approval for a rechargeable version of its deep-brain stimulation implant, allowing for a smaller and thinner neuromodulation device.
The CE mark covers the company’s Percept RC neurostimulator and its BrainSense technology, which records the user’s brain signals so clinicians can chart a course for the therapy among patient-recorded events such as disease symptoms or medication side effects.
“We are excited about the potential of Percept RC to provide a comfortable, personalized DBS therapy to those living with Parkinson’s disease, essential tremor and primary dystonia. Percept RC is also the only rechargeable neurostimulator approved to serve patients with epilepsy,” Amaza Reitmeier, general manager for brain modulation at Medtronic, said in a statement.
The company said...
Today's Sponsors
Today's Sponsor